Evaluation of Efficacy and Safety Parameters of Different Antibiotics Regimens for Management of Empyema

Launched by FAYOUM UNIVERSITY · Jan 16, 2025

Keywords

ClinConnect Summary

This clinical trial is studying how different antibiotic treatments work for people with empyema, which is a condition where fluid builds up in the space around the lungs, often due to infection. Researchers want to find out if using single antibiotics or combinations of antibiotics is more effective and safe for patients. The trial is currently looking for participants who are adults aged 18 and older and have been diagnosed with empyema through imaging tests and lab analysis.

If eligible, participants can expect to receive one of the antibiotic treatments being studied and will be monitored for how well the treatment works and any side effects. However, individuals with allergies to the antibiotics used, severe kidney problems, pregnant or breastfeeding women, and those with empyema caused by tuberculosis will not be able to join the study. This trial aims to improve the way empyema is treated, helping doctors provide better care for patients in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Confirmed Diagnosis of Empyema: Patients with a clinical and radiological diagnosis of
• Exclusion Criteria:
• • 1 - Hypersensitivity or Allergy to the selected antibiotic: Patients with a known history of hypersensitivity or allergic reactions to used antibiotics.
• • 2- Pregnancy and Lactation